Mission
To create a world where medical services can be accessed with technology anywhere, anytime
Vision
Through the power of technology, we strive to support all healthcare professionals and to create a world where better medical services can be accessed.
Value
- Prioritize the customer.
- Businesses don't exist without customers and our first priority is to solve their problems and ensure their satisfaction.
- Move forward quickly without compromising quality.
- Quality is especially important in healthcare where human lives are involved. We ensure the quality of our work. For startups, speed is just as important as quality. It's worthwhile how quickly you accomplish the task.
- Opt for decisions that will substantially propel the business forward.
- If there are several ways or options, choose the one that will move the business forward the most.
- Think positively and move forward.
- When striving to achieve something new, there is a big possibility to face numerous obstacles. It is important to overcome them with a positive mindset and continue moving forward.
- Respect individuality and the various styles of work and thinking.
- Diversity brings new perspectives and values, enabling the sustainable growth of the company.
- Play as a team.
- We are a team brought together to accomplish a common mission, and team play is very important.
- Excel in professionalism as individuals.
- We all should take pride and responsibility in our work.
- Take thoughtful action proactively.
- Instead of being passive, we should thoroughly think for ourselves and take proactive steps towards achieving their goals.
- Grow both as a company and as individuals.
- Through our business, we will not only grow the company significantly, but also grow as individuals.
Board Members
Directors
-
CEO
Osamu Iizuka
-
Board of Director
Masayuki Tsuneki
As a pathology researcher and university faculty member, engaged in molecular pathology research on carcinogenesis at national universities, Yale University, and the National Cancer Center of Japan. Dedicated to developing innovative technologies that bring scientific evidence to clinical pathology, enabling objective and accurate diagnoses. Specialized in human pathology, with strong expertise in interdisciplinary and international research and development.
-
Board of Director
Atsushi Murakami
After passing the Certified Public Accountant examination, worked as a manager at a major audit firm, overseeing accounting audits as well as providing advisory services such as IPO preparation, business planning, and financial due diligence. Since August 2019, leading the Corporate Planning Department at Medmain Inc., and working on building management systems for pre-IPO companies, delivering accounting advisory services to listed companies, and managing a wide range of finance and accounting operations across various business stages.
-
Board of Director
Yusuke Asada
Founded the life sciences business at Sumitomo Electric Industries, Ltd., launching digital health products. Led business development in the biohealth and AI field at Digital Garage, Inc., and drove new business creation at Santen Pharmaceutical Co., Ltd. Joined Medmain in 2021, as Product Manager and Head of AI Alliance, before being appointed Chief Product Officer in 2023. Earned a Ph.D. in Science from The University of Osaka Graduate School and also serves as a visiting lecturer at Kyoto Prefectural University of Medicine.
Outside Directors
-
Outside Director
Katsumasa Niki
Head of the Investment Division at SoftBank Group Corp. until 2016, responsible for domestic and global investments across various stages. Involved in major M&As such as Vodafone Japan and Sprint, as well as investments in overseas technology companies and startups, served as a director worldwide. Also served on the investment committees of multiple venture capital firms in Japan and abroad. Currently President & CEO of DEEPCORE Inc., an AI-focused incubator and venture capital firm, supporting startups.
-
Outside Director
Shigeo Nakano
After graduating from Keio University School of Medicine and completing a graduate degree at the same university, worked at the University of Occupational and Environmental Health and the Division of Pathology, Faculty of Medicine, Saga University. Later conducted research in dermatopathology diagnosis at the Dermatopathology Lab of Thomas Jefferson University in the United States. Upon returning to Japan, established a medical institution specializing in pathology diagnosis. Currently General Manager of the Kanto Regional Headquarters and Head of the Pathology Department at the Kamachi Group, overseeing hospital management and pathology diagnosis. Specializes in dermatopathology.
-
Outside Director
Yukako Yokota
Started a career as a researcher at Biogen Inc., and obtained PhD in Neuroscience. Joined McKinsey & Company, Inc. As Partner, led numerous multi-year projects for healthcare and medical device companies worldwide, covering company-wide transformations, strategy development, global business expansion, and operational improvement. Currently partner at One Capital, overseeing the healthcare sector.
-
Outside Director
Tomohiro Tanaka
Nearly two decades in the sales of medical imaging management systems, from the early stages of digitizing radiological image data to today’s mature market, following joining TechMatrix Corporation. After PSP Corporation and NOBORI Ltd. merged in 2022, served as Head of Sales, driving the PACS business and developing business plans. Currently leading the launch of a new cloud-based pathology imaging solution.
Audit & Supervisory Board Members
-
Auditor
Munehiro Inoue
Certified Public Accountant, Tax Accountant, and Software Engineer. Joined an audit firm in 2007, engaging in accounting audits. From 2011, served as Director of Administration at Aratana Inc., overseeing corporate planning, accounting and finance, legal affairs, and general administration, and contributing to IPO preparation and fundraising. Became independent in 2015, establishing his own CPA and Tax Accountant office, and currently provides broad corporate support through expertise in accounting, taxation, and IT.
Company
| Company name | Medmain Inc. |
|---|---|
| Office |
[ Fukuoka ] 104,2-4-5 Akasaka Chuo-ku Fukuoka, 810-0042 Japan [ Tokyo ] A-Aoyama Building 2F, 2-10-11 Minami Aoyama, Minato-ku,Tokyo,Japan [ US ] 212 Homer Ave, Palo Alto, CA 94301 USA (Medmain USA Inc.) |
| CEO | Osamu Iizuka |
| Date founded | Jan 11th 2018 |
| Capital | JPY 1,190,000,000 (Capital reserve included) |
| Main business activities | Planning, development, operation and sales of medical software products, cloud service |
| Certification |
Certification Standards：ISO/IEC 27001:2022 and JIS Q 27001:2023 Registration Number：JP24/00000322 Certification Scope：Planning, development, operation and sales of medical software products, cloud service First Registration Date：November 4, 2024 Certification Body：SGS Japan Inc. 
Certification Standards：ISO13485：2016 Registration Number：50301629 MP2016 Certification Scope：The design of software for pathology diagnostic support First Registration Date：January 27, 2025 Certification Body：DQS Japan Inc |
As a student at the Department of Medicine, Kyushu University School of Medicine, engaged in extensive software development, focusing on AI and web development with deep learning and machine learning. After working as a software engineer at a venture company and winning a pitch contest in Silicon Valley, founded Medmain Inc. in 2018. Received awards including Forbes 30 Under 30 Asia and the Kyushu University President's Award.